BioCryst Pharmaceuticals
BCRX
#5073
Rank
S$2.07 B
Marketcap
S$9.84
Share price
-3.07%
Change (1 day)
-3.44%
Change (1 year)

Number of shares outstanding for BioCryst Pharmaceuticals (BCRX)

Number of shares outstanding as of December 2025 : 210,176,000

According to BioCryst Pharmaceuticals 's latest financial reports and stock price the company's current number of shares outstanding is 210,176,000. At the end of 2025 the company had 210,176,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.

Shares outstanding history for BioCryst Pharmaceuticals from 1996 to 2025

Shares Outstanding at the end of each year

Year Shares Outstanding Change
20250.21 B1.35%
20240.20 B2.97%
20230.20 B7.75%
20220.18 B2.79%
20210.18 B2.96%
20200.17 B34.51%
20190.13 B19.58%
20180.10 B11.59%
201798.4 M33.4%
201673.76 M0.57%
201573.34 M2.06%
201471.86 M21.62%
201359.09 M16.13%
201250.88 M12.63%
201145.17 M0.66%
201044.88 M16.7%
200938.46 M0.96%
200838.09 M11.14%
200734.27 M17.3%
200629.22 M11.5%
200526.2 M20.75%
200421.7 M22.74%
200317.68 M0.2%
200217.65 M0.48%
200117.56 M0.24%
200017.52 M15.9%
199915.11 M6.39%
199814.21 M2.32%
199713.88 M27.78%
199610.86 M

Shares Outstanding for similar companies or competitors

Company Shares Outstanding differencediff. Country
Repligen
RGEN
56,265,000-73.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
100,237,000-52.31%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
16,026,318-92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
162,353,000-22.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
1,243,000,000 491.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
66,420,000-68.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
2,017,000,000 859.67%๐Ÿ‡ฌ๐Ÿ‡ง UK
Emergent BioSolutions
EBS
53,200,000-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
4,150,702-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA